Literature DB >> 1181385

Micro- and macrovascular changes as the direct cause of parenchymal destruction in congenital murine hydrocephalus.

M Wozniak, D G McLone, A J Raimondi.   

Abstract

Microangiotomography was used to identify the normal and pathological pattern of cerebral vessels in the hy-3 murine mutant mouse (normal and hydrocephalic) at various developmental stages from birth through 21 days of life. The technique employed allows resolution, in the range of 7 to 10 mu of the surface and intraparenchymal (perforating) microvasculature. Ventricular enlargement causes displacement of primary cerebral arteries, followed by both stretching and a decrease in the caliber of primary, secondary, and tertiary vessels (arterial and venous). Ultimately, there is a reduction in the number and caliber of the microvasculature, resulting in diminished cerebral blood flow and cerebral edema. Tissue destruction leading to ependymal rupture, parenchymal cavitation, and the formation of porencephalic cysts within the edematous parenchyma ensues. External ventricular drainage, by decompressing the ventricles, resulted in rapid restoration of the filling of the primary and secondary vessels, thereby suggesting the primary role of vascular changes in the production of brain damage. This study offers experimental evidence that early diversion of the cerebrospinal fluid interrupts this chain of events in congenital murine hydrocephalus.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1181385     DOI: 10.3171/jns.1975.43.5.0535

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  31 in total

1.  Cerebral blood-flow velocity patterns in post-hemorrhagic ventricular dilation.

Authors:  K Lui; J Hellmann; A Sprigg; A Daneman
Journal:  Childs Nerv Syst       Date:  1990-08       Impact factor: 1.475

2.  Changes in the cerebral vascular bed in experimental hydrocephalus: an angio-architectural and histological study.

Authors:  J Nakada; N Oka; T Nagahori; S Endo; A Takaku
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

3.  Hydrocephalus decreases arterial spin-labeled cerebral perfusion.

Authors:  K W Yeom; R M Lober; A Alexander; S H Cheshier; M S B Edwards
Journal:  AJNR Am J Neuroradiol       Date:  2014-03-20       Impact factor: 3.825

4.  A near infrared spectroscopy study investigating oxygen utilisation in hydrocephalic rats.

Authors:  Zareen Bashir; Jemma Miller; Jaleel Ahmad Miyan; Maureen Susan Thorniley
Journal:  Exp Brain Res       Date:  2006-05-30       Impact factor: 1.972

5.  Optic chiasmal edema observed on T2-weighted MR images: a reversible finding in obstructive hydrocephalus.

Authors:  Takashi Hiyama; Tomohiko Masumoto; Masanari Shiigai; Hiroyoshi Akutsu; Akira Matsumura; Manabu Minami
Journal:  Jpn J Radiol       Date:  2015-01-29       Impact factor: 2.374

Review 6.  Mechanisms and evolution of the brain damage in neonatal post-hemorrhagic hydrocephalus.

Authors:  F Guzzetta; E Mercuri; M Spanò
Journal:  Childs Nerv Syst       Date:  1995-05       Impact factor: 1.475

7.  Outcome of patients with aneurysmal and presumed aneurysmal bleeding. A hospital study based on 100 consecutive cases in a neurological clinic.

Authors:  H Schütz; P Krack; B Buchinger; R H Bödeker; A Laun; W Dorndorf; A Agnoli
Journal:  Neurosurg Rev       Date:  1993       Impact factor: 3.042

Review 8.  A unifying theory for the definition and classification of hydrocephalus.

Authors:  A J Raimondi
Journal:  Childs Nerv Syst       Date:  1994-01       Impact factor: 1.475

9.  Cerebrovascular resistive index assessed by duplex Doppler sonography and its relationship to intracranial pressure in infantile hydrocephalus.

Authors:  D Goh; R A Minns; G M Hendry; M Thambyayah; A J Steers
Journal:  Pediatr Radiol       Date:  1992

10.  The significance of periventricular lucency on computed tomography: experimental study with canine hydrocephalus.

Authors:  T Murata; H Handa; K Mori; Y Nakano
Journal:  Neuroradiology       Date:  1981-01       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.